Sale!

LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LAMA2 gene muscular dystrophy Type 1A genetic test is a specialized diagnostic procedure aimed at detecting mutations in the LAMA2 gene, which are indicative of Muscular Dystrophy Type 1A, also known as Merosin-deficient congenital muscular dystrophy. This condition is characterized by muscle weakness and wasting, primarily affecting the voluntary muscles used for activities such as crawling and walking. Early detection through genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the LAMA2 gene. The presence of these mutations can confirm a diagnosis of Muscular Dystrophy Type 1A, enabling healthcare providers to tailor interventions more effectively and offer support to families dealing with the implications of this genetic condition.

The cost of the LAMA2 gene muscular dystrophy Type 1A genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a definitive diagnosis and the potential to significantly impact the patient’s treatment plan and quality of life can be invaluable. Patients considering this test are encouraged to discuss it with their healthcare provider to fully understand its benefits and implications.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test

Test Name: LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test

Components: DNA sample (Blood or Extracted DNA or One drop Blood on FTA Card)

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for LAMA2 Gene Muscular Dystrophy Type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LAMA2 Gene Muscular Dystrophy Type 1A

What is LAMA2 Gene Muscular Dystrophy Type 1A?

The LAMA2 gene is associated with a specific type of muscular dystrophy called Muscular Dystrophy Type 1A (MDC1A). This type of muscular dystrophy is caused by mutations in the LAMA2 gene, which is responsible for producing a protein called laminin alpha-2. This protein is important for maintaining the structure and function of muscle cells.

About the Genetic Test

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of MDC1A, NGS can be used to analyze the LAMA2 gene for any mutations or variations that may be causing the disease.

The LAMA2 gene NGS genetic test involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having MDC1A. The DNA is then sequenced using NGS technology to identify any mutations or variations in the LAMA2 gene. The results of the test can help confirm a diagnosis of MDC1A and provide information about the specific mutation(s) present in the gene.

Who Should Get Tested?

This genetic test can be useful for individuals with symptoms suggestive of MDC1A, such as muscle weakness, difficulty walking, and delayed motor development. It can also be used for carrier testing in individuals with a family history of MDC1A or for prenatal testing in families with a known LAMA2 gene mutation.

It is important to note that genetic testing for MDC1A should be conducted and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the appropriateness of testing, help interpret the results, and provide information about the implications of the test results for the individual and their family.

Test Name LAMA2 Gene Muscular dystrophy type 1A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LAMA2 Gene Muscular dystrophy type 1A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LAMA2 Gene Muscular dystrophy type 1A
Test Details

The LAMA2 gene is associated with a specific type of muscular dystrophy called Muscular Dystrophy Type 1A (MDC1A). This type of muscular dystrophy is caused by mutations in the LAMA2 gene, which is responsible for producing a protein called laminin alpha-2. This protein is important for maintaining the structure and function of muscle cells.

NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of MDC1A, NGS can be used to analyze the LAMA2 gene for any mutations or variations that may be causing the disease.

The LAMA2 gene NGS genetic test involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having MDC1A. The DNA is then sequenced using NGS technology to identify any mutations or variations in the LAMA2 gene. The results of the test can help confirm a diagnosis of MDC1A and provide information about the specific mutation(s) present in the gene.

This genetic test can be useful for individuals with symptoms suggestive of MDC1A, such as muscle weakness, difficulty walking, and delayed motor development. It can also be used for carrier testing in individuals with a family history of MDC1A or for prenatal testing in families with a known LAMA2 gene mutation.

It is important to note that genetic testing for MDC1A should be conducted and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the appropriateness of testing, help interpret the results, and provide information about the implications of the test results for the individual and their family.